{
  "compound": "CBD (cannabidiol)",
  "condition": "PTSD",
  "effect_size": "Large (91% response rate)",
  "study_type": "RCT",
  "source": "NORML:PTSD_RCT_004",
  "participants": "11 adults with PTSD",
  "year": 2019,
  "notes": "CBD for PTSD: Pilot Randomized Controlled Trial",
  "confidence": "medium",
  "abstract": "91% (10/11) experienced symptom reduction; Mean PCL-5 decreased 28%; Nightmares improved in all patients"
}